Prime Medicine, Inc. Related Party Transaction, Other Revenues from Transactions with Related Party
Prime Medicine, Inc. (PRME) reported Related Party Transaction, Other Revenues from Transactions with Related Party of $126.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-09.
Discontinued › Income Statement › Other Income
us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty · last filed 2023-03-09
- Prime Medicine, Inc. related party transaction, other revenues from transactions with related party for fiscal 2020 was $126.00K.
| Period end | Related Party Transaction, Other Revenues from Transactions with Related Party 12 month |
|---|---|
| 2020-12-31 | $126.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |